AR014881A1 - Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente - Google Patents
Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agenteInfo
- Publication number
- AR014881A1 AR014881A1 ARP980102885A ARP980102885A AR014881A1 AR 014881 A1 AR014881 A1 AR 014881A1 AR P980102885 A ARP980102885 A AR P980102885A AR P980102885 A ARP980102885 A AR P980102885A AR 014881 A1 AR014881 A1 AR 014881A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- sensitizer
- preparation
- antihiperglucemic
- understands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
Abstract
Uso de un sensibilizador a insulina y un agente antihiperglucémico para la preparacion de un medicamento util para el tratamiento de la diabetes mellitusy condiciones asociadas con la diabetes mellitus en un mamífero, que comprende una cantidad eficaz no toxica y farmacéuticamente aceptable de unsensibilizador a insulina y de un agente antihiperglucémico inhibidor de alfa-glucosidasa, a un mamífero que necesita de ello; y composicionfarmacéutica que comprende dicho sensibilizador y dichoagente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014881A1 true AR014881A1 (es) | 2001-04-11 |
Family
ID=26311746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102882A AR013352A1 (es) | 1997-06-18 | 1998-06-17 | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica. |
| ARP980102885A AR014881A1 (es) | 1997-06-18 | 1998-06-17 | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102882A AR013352A1 (es) | 1997-06-18 | 1998-06-17 | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica. |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0975343A1 (es) |
| JP (1) | JP2001523271A (es) |
| KR (1) | KR20010013845A (es) |
| CN (1) | CN1274282A (es) |
| AP (1) | AP9901720A0 (es) |
| AR (2) | AR013352A1 (es) |
| AU (1) | AU8799998A (es) |
| BG (1) | BG103966A (es) |
| BR (1) | BR9810186A (es) |
| CA (1) | CA2294134A1 (es) |
| CO (1) | CO4940453A1 (es) |
| DZ (1) | DZ2519A1 (es) |
| EA (1) | EA200000040A1 (es) |
| IL (1) | IL133138A0 (es) |
| MA (1) | MA26510A1 (es) |
| NO (1) | NO996270D0 (es) |
| NZ (1) | NZ501345A (es) |
| OA (1) | OA11631A (es) |
| PE (1) | PE89199A1 (es) |
| PL (1) | PL337577A1 (es) |
| SK (1) | SK179499A3 (es) |
| TR (1) | TR199903072T2 (es) |
| UY (1) | UY25051A1 (es) |
| WO (1) | WO1998057635A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| OA11871A (en) | 1999-04-23 | 2006-03-27 | Smithkline Beecham Plc | Novel pharmaceutical. |
| US20030045553A1 (en) | 2001-04-04 | 2003-03-06 | Bussolari Jacqueline C. | Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| US6838442B2 (en) | 2001-04-04 | 2005-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators |
| FR2832930A1 (fr) * | 2001-12-03 | 2003-06-06 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
| JP2004067575A (ja) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | 糖尿病治療薬効果促進剤 |
| CN101121004B (zh) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | 含有胰岛素增敏剂和米格列醇的药物组合物 |
| CN101584705B (zh) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
| CN101584688B (zh) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993003724A1 (en) * | 1991-08-26 | 1993-03-04 | The Upjohn Company | Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride |
| US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
| TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/ko not_active Application Discontinuation
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 PL PL98337577A patent/PL337577A1/xx unknown
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 JP JP50375699A patent/JP2001523271A/ja not_active Ceased
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Application Discontinuation
- 1998-06-15 SK SK1794-99A patent/SK179499A3/sk unknown
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/xx unknown
- 1998-06-15 EA EA200000040A patent/EA200000040A1/ru unknown
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 IL IL13313898A patent/IL133138A0/xx unknown
- 1998-06-15 CN CN98806319A patent/CN1274282A/zh active Pending
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/pt not_active IP Right Cessation
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/xx active
- 1998-06-17 MA MA25121A patent/MA26510A1/fr unknown
- 1998-06-17 AR ARP980102882A patent/AR013352A1/es unknown
- 1998-06-17 AR ARP980102885A patent/AR014881A1/es unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/es not_active Application Discontinuation
- 1998-06-18 UY UY25051A patent/UY25051A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/es unknown
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/bg unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1274282A (zh) | 2000-11-22 |
| CA2294134A1 (en) | 1998-12-23 |
| PE89199A1 (es) | 1999-10-23 |
| PL337577A1 (en) | 2000-08-28 |
| NO996270L (no) | 1999-12-17 |
| NZ501345A (en) | 2001-10-26 |
| IL133138A0 (en) | 2001-03-19 |
| MA26510A1 (fr) | 2004-12-20 |
| EP0975343A1 (en) | 2000-02-02 |
| TR199903072T2 (xx) | 2000-07-21 |
| BG103966A (bg) | 2000-07-31 |
| UY25051A1 (es) | 2000-09-29 |
| WO1998057635A1 (en) | 1998-12-23 |
| DZ2519A1 (fr) | 2003-02-01 |
| EA200000040A1 (ru) | 2000-08-28 |
| AR013352A1 (es) | 2000-12-27 |
| JP2001523271A (ja) | 2001-11-20 |
| KR20010013845A (ko) | 2001-02-26 |
| OA11631A (en) | 2004-11-22 |
| CO4940453A1 (es) | 2000-07-24 |
| SK179499A3 (en) | 2000-11-07 |
| AP9901720A0 (en) | 1999-12-31 |
| BR9810186A (pt) | 2000-08-08 |
| NO996270D0 (no) | 1999-12-17 |
| AU8799998A (en) | 1999-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012998A1 (es) | Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprende dichosensibilizador y dicho agente. | |
| UY25799A1 (es) | Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina y otro agente antidiabético. | |
| CL2009001899A1 (es) | Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01). | |
| AR033688A1 (es) | Composicion parenteral reconstituible | |
| AR005281A1 (es) | Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. . | |
| SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
| CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
| AR014881A1 (es) | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente | |
| BR9810445A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida | |
| UY25798A1 (es) | Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina tiazolidinadiónico. | |
| AR015894A1 (es) | Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos | |
| AR016350A1 (es) | Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos | |
| AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
| UY25103A1 (es) | Composición para el tratamiento de diabetes mellitus | |
| AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
| AR007058A1 (es) | Uso de interferon en medicamentos y composiciones para contacto oromucosal | |
| ECSP982541A (es) | Nuevo metodo de tratamiento ii | |
| ECSP982535A (es) | Nuevo metodo de tratamiento (i) | |
| ECSP993215A (es) | Nueva composicion y uso | |
| ECSP982591A (es) | Nuevo metodo de tratamiento iv | |
| ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
| ECSP982592A (es) | Nuevo metodo de tratamiento v | |
| CO5270004A1 (es) | Composiciones farmaceuticas con agente del tipo biguanida para tratamientos en diabetes | |
| ECSP993216A (es) | Nueva composicion y uso ii | |
| RU94019942A (ru) | Фармацевтическая композиция для повышения проницаемости кожи для улучшенной локальной доставки лекарств |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |